1. Home
  2. SUNS vs CRBP Comparison

SUNS vs CRBP Comparison

Compare SUNS & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$7.87

Market Cap

126.3M

Sector

Real Estate

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$10.68

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
CRBP
Founded
2023
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.3M
147.4M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SUNS
CRBP
Price
$7.87
$10.68
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$8.75
$45.60
AVG Volume (30 Days)
116.1K
226.8K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
15.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
$70.81
N/A
Revenue Next Year
N/A
$116.00
P/E Ratio
$8.84
N/A
Revenue Growth
N/A
97.62
52 Week Low
$7.46
$6.10
52 Week High
$11.78
$20.56

Technical Indicators

Market Signals
Indicator
SUNS
CRBP
Relative Strength Index (RSI) 41.11 63.28
Support Level $7.46 $7.91
Resistance Level $10.27 $11.64
Average True Range (ATR) 0.22 0.71
MACD 0.05 0.06
Stochastic Oscillator 58.73 85.59

Price Performance

Historical Comparison
SUNS
CRBP

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: